A Multicentre Randomized Clinical Trial on Efficacy and Safety of Huxin Formula in Patients Undergoing Percutaneous Coronary Intervention

Table 5

Score of the quality of life scale for patients with unstable angina (𝑥±𝑠).

Time	Group	𝑛	𝑥±𝑠	𝑍	𝑃
0 day	Control group	168	69.61±11.27	−0.32	0.75
	Treatment group	193	69.97±10.65
90 days	Control group	168	80.75±8.94	−0.53	0.59
	Treatment group	193	81.09±8.86
180 days	Control group	168	82.44±9.03	−1.06	0.29
	Treatment group	193	83.33±8.11
270 days	Control group	168	84.78±8.18	−0.72	0.47
	Treatment group	193	85.23±8.25
360 days	Control group	168	85.70±8.08	−2.51	0.01^#
	Treatment group	193	87.62±7.52

^#Significantly different versus control group (𝑃<0.05).